Ketamine in Bariatric Surgery

University of Padova

Status and phase: Unknown; Phase 3

Conditions: Morbid Obesity

Treatments: Drug: fentanyl; Drug: ketamine

Study type: Interventional

Funder types: Other

Identifiers

NCT01724983

KET2271

Details and patient eligibility

About

Ketamine may improve recovery from bariatric surgery.

Enrollment: 90 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age > 18
• obesity (Body Mass Index > 30)
• ASA classificazion < 4
• candidate to bariatric surgery

Exclusion criteria

• known or presumed pregnancy
• previous surgery on the airway, esophagus or stomach
• uncontrolled psychiatric symptomatology

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

90 participants in 2 patient groups

ketamine

Experimental group

Description:

patients will receive ketamine at induction

Treatment:

Drug: ketamine

fentanyl

Active Comparator group

Description:

patients will receive fentanyl at induction

Treatment:

Drug: fentanyl